# FDA recall D-0836-2020

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2020-01-27.

## Product

Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-725-01

## Reason for recall

CGMP deviations: Product bottle may be absent of desiccant.

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0836-2020
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-01-27
- **Report date:** 2020-02-19
- **Termination date:** 2020-11-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0836-2020

## Citation

> AI Analytics. FDA recall D-0836-2020. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0836-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*